Blog
NETRF Announces $2.5 Million in Research to Advance the NETs
New grants to explore CAR-T, PRRT, a vaccine for NETs and other innovative approaches.
February 1, 2019
No Comments
Category: NETRF News
About NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Blog
Tb-161: Novel Radionuclide to be Tested
Early Research on Targeting Single Cancer Cells to Prevent Metastasis Despite the effectiveness of Peptide Receptor Radionuclide Therapy (PRRT) to prolong survival of those with
October 16, 2018
3 Comments
Blog
CarGurus Makes Grant to NETRF
The Neuroendocrine Tumor Research Foundation (NETRF) gratefully received a $35,000 donation for NET research from the CarGurus Charitable Giving Fund. NETRF was nominated by a
October 16, 2018
No Comments
Blog
New Grant Explores Novel Drug Delivery System
Antibody-drug conjugate aims to combine the benefits of targeted therapy and chemotherapy Renata Jaskula-Sztul, PhD, Assistant Professor of Surgical Oncology at the University of Alabama
October 15, 2018
2 Comments
Blog
Brendan P. Foley Jr. Joins NETRF Board of Directors
We are proud to welcome Brendan P. Foley, Jr. as the newest member of the NET Research Foundation Board of Directors. Brendan has been elected
October 15, 2018
No Comments
Blog
Spark Hope: A $10 Million Campaign for NET Research
NETRF has launched a $10 million fundraising campaign, the largest of its kind in our history. Every gift we receive will be MATCHED, doubling our
October 11, 2018
No Comments
Blog
Leaving Neuroendocrine Cancer Behind
NET Survivor Finds Hope and Inspiration That’s it—my number is up, Dave McCoy thought when he learned he had neuroendocrine cancer in 2008. A cancer, he
October 11, 2018
5 Comments
Blog
NET Research Foundation Seeks to Raise $10 Million with Spark Hope Campaign
Research Aimed at Expanding Effective Treatment Options for Neuroendocrine Tumors The Neuroendocrine Tumor Research Foundation, Boston, MA, the leading funder of neuroendocrine tumor (NET) research,
September 27, 2018
No Comments
Blog
Immunotherapy Update: What We’ve Learned
Immunotherapy has been called one of the most significant advances in cancer in decades. While this approach may work in some cancers, it is unclear
September 11, 2018
1 Comment
Blog
The passing of Aretha Franklin, Queen of Soul
We are saddened to hear of the passing of Aretha Franklin, the Queen of Soul, who died of a pancreatic neuroendocrine tumor (pNET). She was
August 16, 2018
2 Comments